HSF1 and liver cancer: Cooperating with STAT3, HSF1 is able to maintain the cancerous phenotype of liver cancer cells [34], and the inhibition of HSF1 in pancreatic cancer decreases their stemness and sensitizes them to gemcitabine [35].